Stem Cells_990x120
watch on demand (2)
If you have already registered, follow this link and enter your e-mail address into the "Already Registered?" field to view the webinar.

Event Overview

Stem cells are valuable for neurological disease research and drug development as they permit the in vitro construction of disease models. Human pluripotent stem cells (hPSCs), including human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (ESCs), offer unique advantages for developmental studies. They can be employed in a patient-specific way to identify molecular lesions and aid in therapeutic development. To examine the potential of stem cells for in vitro modeling of neurological disease, The Scientist is bringing together a panel of experts to discuss their research and provide insight into these exciting techniques.

Topics to be Covered
  • Investigating the dynamic nature of the brain in the context of disease and injury using stem cell biology
  • Neurological disease modeling with induced pluripotent stem cells
Wednesday, October 9, 2019
2:30 - 4:00 PM Eastern Time


Jaime Imitola.png
Jaime Imitola, MD, FAAN
Director, Division of Multiple Sclerosis and Translational Neuroimmunology
Vice-Chair of Neurology Research, Department of Neurology
University of Connecticut, School of Medicine

Mark Hester.png
Mark E. Hester, PhD
Principal Investigator, Institute for Genomic Medicine
Abigail Wexner Research Institute, Nationwide Children’s Hospital, Ohio Assistant Professor, Department of Pediatrics The Ohio State University College of Medicine





Register Now

Stem Cells for In Vitro Modeling of Neurological Disease

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendors of this webinar. The Scientist and our sponsoring vendors may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.